122 related articles for article (PubMed ID: 35342938)
21. Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
Liu H; Zhang B; Sun Z
Cancer Commun (Lond); 2020 Jan; 40(1):43-59. PubMed ID: 32067422
[TBL] [Abstract][Full Text] [Related]
22. Expression of Genes Associated with Telomere Homeostasis in TP53 Mutant LoVo Cell Lines as a Model for Genomic Instability.
Samassekou O; Bastien N; Yan J; Mai S; Drouin R
Methods Mol Biol; 2018; 1769():253-262. PubMed ID: 29564829
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal damage and telomere length in peripheral blood lymphocytes of cancer patients.
Vodenkova S; Kroupa M; Polivkova Z; Musak L; Ambrus M; Schneiderova M; Kozevnikovova R; Vodickova L; Rachakonda S; Hemminki K; Kumar R; Vodicka P
Oncol Rep; 2020 Nov; 44(5):2219-2230. PubMed ID: 33000239
[TBL] [Abstract][Full Text] [Related]
24. Telomere-related Markers for Cancer.
Yuan X; Dai M; Xu D
Curr Top Med Chem; 2020; 20(6):410-432. PubMed ID: 31903880
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Pompili L; Leonetti C; Biroccio A; Salvati E
J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma.
Else T; Giordano TJ; Hammer GD
J Clin Endocrinol Metab; 2008 Apr; 93(4):1442-9. PubMed ID: 18198226
[TBL] [Abstract][Full Text] [Related]
27. Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells.
Sameni S; Hande MP
Biomed Pharmacother; 2016 Aug; 82():256-68. PubMed ID: 27470362
[TBL] [Abstract][Full Text] [Related]
28. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Jafri MA; Ansari SA; Alqahtani MH; Shay JW
Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
[TBL] [Abstract][Full Text] [Related]
29. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
[TBL] [Abstract][Full Text] [Related]
30. Radiation and chemotherapy bystander effects induce early genomic instability events: telomere shortening and bridge formation coupled with mitochondrial dysfunction.
Gorman S; Tosetto M; Lyng F; Howe O; Sheahan K; O'Donoghue D; Hyland J; Mulcahy H; O'Sullivan J
Mutat Res; 2009 Oct; 669(1-2):131-8. PubMed ID: 19540247
[TBL] [Abstract][Full Text] [Related]
31. Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome.
Lu L; Zhang C; Zhu G; Irwin M; Risch H; Menato G; Mitidieri M; Katsaros D; Yu H
Breast Cancer Res; 2011 Jun; 13(3):R56. PubMed ID: 21645396
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Heaphy CM; Subhawong AP; Hong SM; Goggins MG; Montgomery EA; Gabrielson E; Netto GJ; Epstein JI; Lotan TL; Westra WH; Shih IeM; Iacobuzio-Donahue CA; Maitra A; Li QK; Eberhart CG; Taube JM; Rakheja D; Kurman RJ; Wu TC; Roden RB; Argani P; De Marzo AM; Terracciano L; Torbenson M; Meeker AK
Am J Pathol; 2011 Oct; 179(4):1608-15. PubMed ID: 21888887
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
34. G-quadruplex ligands targeting telomeres do not inhibit HIV promoter activity and cooperate with latency reversing agents in killing latently infected cells.
Piekna-Przybylska D; Bambara RA; Maggirwar SB; Dewhurst S
Cell Cycle; 2020 Sep; 19(18):2298-2313. PubMed ID: 32807015
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activity in pleural malignant mesotheliomas.
Au AY; Hackl T; Yeager TR; Cohen SB; Pass HI; Harris CC; Reddel RR
Lung Cancer; 2011 Sep; 73(3):283-8. PubMed ID: 21277646
[TBL] [Abstract][Full Text] [Related]
36. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
[TBL] [Abstract][Full Text] [Related]
37. Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer.
Sun J; Jiang Q; Chen H; Zhang Q; Zhao J; Li H; Wang X; Fang Y; Ruan Y; Sun Y
Ann Transl Med; 2021 Aug; 9(16):1326. PubMed ID: 34532463
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms that drive telomere maintenance and recombination in human cancers.
Sobinoff AP; Pickett HA
Curr Opin Genet Dev; 2020 Feb; 60():25-30. PubMed ID: 32119936
[TBL] [Abstract][Full Text] [Related]
39. Telomere-related genome instability in cancer.
De Lange T
Cold Spring Harb Symp Quant Biol; 2005; 70():197-204. PubMed ID: 16869754
[TBL] [Abstract][Full Text] [Related]
40. The prognostic landscape of genes and infiltrating immune cells across human cancers.
Gentles AJ; Newman AM; Liu CL; Bratman SV; Feng W; Kim D; Nair VS; Xu Y; Khuong A; Hoang CD; Diehn M; West RB; Plevritis SK; Alizadeh AA
Nat Med; 2015 Aug; 21(8):938-945. PubMed ID: 26193342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]